{"organizations": [], "uuid": "2ea22b6d4191ab9558220485c0c3eb887623284c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180122.html", "section_title": "Archive News &amp; Video for Monday, 22 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-harvard-bioscience-to-acquire-data/brief-harvard-bioscience-to-acquire-data-sciences-international-idUSASB0C1RD", "country": "US", "domain_rank": 408, "title": "BRIEF-Harvard Bioscience To Acquire Data Sciences International", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.929, "site_type": "news", "published": "2018-01-23T05:15:00.000+02:00", "replies_count": 0, "uuid": "2ea22b6d4191ab9558220485c0c3eb887623284c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-harvard-bioscience-to-acquire-data/brief-harvard-bioscience-to-acquire-data-sciences-international-idUSASB0C1RD", "ord_in_thread": 0, "title": "BRIEF-Harvard Bioscience To Acquire Data Sciences International", "locations": [], "entities": {"persons": [], "locations": [{"name": "denville", "sentiment": "none"}], "organizations": [{"name": "brief-harvard bioscience to acquire data sciences international", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "harvard bioscience", "sentiment": "negative"}, {"name": "harvard bioscience inc", "sentiment": "negative"}, {"name": "dsi", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - Harvard Bioscience Inc:\n* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC\n* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC\n* HARVARD BIOSCIENCE INC - DEAL FOR APPROXIMATELY $70 MILLION\n* HARVARD BIOSCIENCE INC - ACQUISITION OF DSI WILL BE ACCRETIVE TO EARNINGS AT CLOSING\n* HARVARD BIOSCIENCE INC - ‍AS A RESULT OF TRANSACTIONS, MANAGEMENT EXPECTS COMPANY‘S FISCAL 2018 ANNUAL REVENUE TO BE BETWEEN $118 MILLION AND $123 MILLION​\n* HARVARD BIOSCIENCE INC - AS A RESULT OF TRANSACTIONS, MANAGEMENT EXPECTS COMPANY‘S FISCAL 2018 ANNUAL REVENUE TO BE BETWEEN $118 MILLION AND $123 MILLION\n* HARVARD BIOSCIENCE INC - ACQUISITION OF DSI WILL BE FINANCED THROUGH A COMBINATION OF DEBT, PROCEEDS FROM SALE OF DENVILLE, AND CASH ON HAND\n* HARVARD BIOSCIENCE - EXPECTS TRANSACTION TO GENERATE ABOUT $2.5 MILLION TO $3.5 MILLION IN COMBINED REVENUE & COST SYNERGIES 12 MONTHS FOLLOWING CLOSING\n* HARVARD BIOSCIENCE - EXPECTS COMBINED REVENUE & COST SYNERGIES FROM DEAL TO INCREASE OVER FIRST 3 YEARS FOLLOWING CLOSING\n* HARVARD BIOSCIENCE - AS A RESULT OF TRANSACTIONS MANAGEMENT EXPECTS CO‘S FISCAL 2018 ANNUAL GAAP EPS TO BE BETWEEN $0.03 - $0.07\n* HARVARD BIOSCIENCE - AS A RESULT OF TRANSACTIONS MANAGEMENT EXPECTS CO‘S FISCAL 2018 ANNUAL NON-GAAP ADJUSTED EPS BETWEEN $0.19 AND $0.23 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T05:15:00.000+02:00", "crawled": "2018-01-23T18:16:11.015+02:00", "highlightTitle": ""}